Decode Age has secured ₹14.48 crore in Pre-Series A funding to advance its work in longevity science and gut microbiome research. The round was led by angel investors and early-stage backers. The capital will support Decode Age’s efforts to develop age-related health solutions, expand scientific studies, and build tools to improve long-term wellness and personalised interventions.